These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15506662)

  • 1. Prevention of aspirin-induced gastroduodenal damage: H. pylori infection eradication versus proton pump inhibitors or both.
    Lanas A
    Dig Liver Dis; 2004 Oct; 36(10):655-7. PubMed ID: 15506662
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment.
    Lanas A; Scheiman J
    Curr Med Res Opin; 2007 Jan; 23(1):163-73. PubMed ID: 17257477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NSAID-induced gastrointestinal damage: current clinical management and recommendations for prevention.
    Lanas A; Ferrandez A
    Chin J Dig Dis; 2006; 7(3):127-33. PubMed ID: 16808792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal bleeding associated with low-dose aspirin use: relevance and management in clinical practice.
    Lanas A
    Expert Opin Drug Saf; 2011 Jan; 10(1):45-54. PubMed ID: 20645883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Should Helicobacter pylori infection be tested and eradicated in patients treated or about to be treated with aspirin or nonsteroidal anti-inflammatory drugs?].
    Thiéfin G
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):415-26. PubMed ID: 12700498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary care physician perceptions of non-steroidal anti-inflammatory drug and aspirin-associated toxicity: results of a national survey.
    Chey WD; Eswaren S; Howden CW; Inadomi JM; Fendrick AM; Scheiman JM
    Aliment Pharmacol Ther; 2006 Mar; 23(5):655-68. PubMed ID: 16480405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin?
    Chan FK
    Chin J Dig Dis; 2005; 6(1):1-5. PubMed ID: 15667550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case for proton pump blocker... When cough comes from the stomach].
    Wepner U
    MMW Fortschr Med; 2002 Nov; 144(45):10-2. PubMed ID: 12534054
    [No Abstract]   [Full Text] [Related]  

  • 10. Review article: the unmet needs in delayed-release proton-pump inhibitor therapy in 2005.
    Hunt RH
    Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():10-9. PubMed ID: 16303032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptic ulcer disease today.
    Yuan Y; Padol IT; Hunt RH
    Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):80-9. PubMed ID: 16456574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies to reduce the GI risks of antiplatelet therapy.
    Scheiman JM
    Rev Cardiovasc Med; 2005; 6 Suppl 4():S23-31. PubMed ID: 17710073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathogen eradication prevents gastrointestinal complications].
    MMW Fortschr Med; 2007 Oct; 149(43):58-9. PubMed ID: 17992910
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk Factors for Upper GI Damage in Low-Dose Aspirin Users and the Interaction Between H. pylori Infection and Low-Dose Aspirin Use.
    Iijima K; Shimosegawa T
    Curr Pharm Des; 2015; 21(35):5056-65. PubMed ID: 26369687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment and prophylaxis of alimentary tract lesions caused by non-steroid anti-inflammatory drugs].
    Gil J; Wojtuń S
    Pol Merkur Lekarski; 2009 May; 26(155):353-7. PubMed ID: 19606672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antithrombotic drug and gastrointestinal injuries].
    Kawai T; Fukuzawa M; Moriyasu F; Yamashina A
    Nihon Rinsho; 2013 Feb; 71(2):365-8. PubMed ID: 23631222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of and risk factors for upper gastrointestinal complications in patients taking low-dose aspirin in Japan.
    Fujisawa N; Inamori M; Endo H; Uchiyama T; Hosono K; Akiyama T; Tomimoto A; Koyama S; Sawabe A; Tanida E; Yanagisawa S; Hata Y; Okada K; Atsukawa K; Watanabe S; Kawamura H; Higurashi T; Nagase H; Akimoto K; Matsuhashi N; Nakajima A
    Hepatogastroenterology; 2011; 58(105):229-34. PubMed ID: 21510320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.
    Vergara M; Catalán M; Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2005 Jun; 21(12):1411-8. PubMed ID: 15948807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori infection, but not low-dose aspirin, results in a local reduction of the secretory leukocyte protease inhibitor in gastroduodenal mucosa.
    Wex T; Ye S; Treiber G; Vieth M; Roessner A; Malfertheiner P
    Helicobacter; 2006 Feb; 11(1):31-8. PubMed ID: 16423087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.